VRNA - Verona Pharma plc
106.91
0.120 0.112%
Share volume: 1,871,959
Last Updated: 10-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$106.79
0.12
0.00%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 02-27-2025 | 04-29-2025 | 08-06-2025 | |
| Total revenue | 36.655 M | 76.256 M | 103.138 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 36.655 M | 76.256 M | 103.138 M | |
| 108.04% | 35.25% | |||
| Operating expenses | 54.994 M | 86.573 M | 89.833 M | |
| Selling general and admin | 47.124 M | 72.519 M | 76.883 M | |
| Research and development | 7.870 M | 14.054 M | 12.950 M | |
| Total expenses | 54.994 M | 86.573 M | 89.833 M | |
| 57.42% | 3.77% | |||
| Operating income | -18.339 M | -10.317 M | 13.305 M | |
| Ebit | -19.233 M | -9.847 M | 14.402 M | |
| Pretax income | -25.556 M | -16.558 M | 11.882 M | |
| -35.21% | -171.76% | |||
| Income tax | 8.271 M | -239.000 K | -39.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -33.827 M | -16.319 M | 11.921 M | |
| 51.76% | 173.05% |